Eamon Murphy started exhibiting mental aberrations and problems eating at three months of age. By the time he was three, his parents were frantically trying to understand what had caused his developmental delay in walking and talking, and now his trances, seizure-like episodes and regression. After a determined effort by his mother and a series of extraordinarily lucky events, he was finally diagnosed with celiac disease…and Read More »
Olmesartan Blood Pressure Medicine Linked to Celiac Disease Type Villous Atrophy
I just received an email from the Celiac Disease Research Center at Columbia University regarding a study showing a possible association between a blood pressure medication and villous atrophy. The blood pressure medication is called olmesartan and it is also known as Benicar, Benicar HCT, Azor, and Olmetec.
According to this article, the three-year study was conducted by the Mayo Clinic in Rochester, Minnesota and it included 22 patients who had symptoms of celiac disease, but antibody blood tests did not support that diagnosis. During this study patients improved with discontinuation of the drug, while a gluten-free diet had had no impact on their Read More »
Research Study on Genetic Testing Looking for Survey Participants
April 12, 2011	1 Comment
The Celiac Disease Center at Columbia University invites you to participate in a research study looking at individuals’ knowledge of genetic testing of celiac disease and their potential concerns with such testing. The goal of this study is to increase understanding of the factors associated with making an informed decision regarding such testing and to better provide the necessary information to make such a decision.
A brief survey has been developed to address some of these factors. The survey only takes five minutes to complete, it is anonymous, and no identifying information is collected.
If you or a family member has celiac disease or gluten sensitivity, Read More »
Study reports those diagnosed with celiac disease have reduced subsequent healthcare costs
According to the National Digestive Diseases Information Clearing House, a study published in the December 2008 issue of the Journal of Insurance Medicine reports that researchers from Columbia University and CIGNA HealthCare found that diagnosis of celiac disease substantially reduces subsequent health care costs.
The research group, led by Peter Green, M.D., a renowned authority in celiac disease from Columbia University, looked at medical records for 10.2 million CIGNA managed care members. Read More »
Columbia Celiac Disease Center needs participants for survey (SURVEY IS CLOSED)
The Celiac Disease Center at Columbia University is starting a research study to assess the knowledge of chefs and the general public about celiac disease. They are also looking at people who follow the gluten-free diet (because of celiac disease or gluten sensitivity) and whether their quality of life with respect to restaurant eating is affected because of the diet.
Columbia University Celiac Disease Center Roundtable Discussion June 7
This just in from the Celiac Disease Center at Columbia University…
The Celiac Disease Center at Columbia University will continue to host a Roundtable on Celiac Disease that deals with individuals and their families’ difficulties in living with celiac disease. The program will be held monthly and would deal with children, adolescence and adult issues with respect to celiac disease.